C Radzikowski

778 total citations
72 papers, 656 citations indexed

About

C Radzikowski is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, C Radzikowski has authored 72 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 19 papers in Immunology and 17 papers in Oncology. Recurrent topics in C Radzikowski's work include Glycosylation and Glycoproteins Research (11 papers), Immunotherapy and Immune Responses (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). C Radzikowski is often cited by papers focused on Glycosylation and Glycoproteins Research (11 papers), Immunotherapy and Immune Responses (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). C Radzikowski collaborates with scholars based in Poland, Czechia and France. C Radzikowski's co-authors include Adam Opolski, W Budzyński, Joanna Wietrzyk, Danuta Duś, Z Kleinrok, Maria Paprocka, Andrzej Kutner, Agnieszka Chrobak, Jerzy Konopa and Ewa Marcinkowska and has published in prestigious journals such as Current Pharmaceutical Design, Clinical & Experimental Metastasis and Oncology Reports.

In The Last Decade

C Radzikowski

71 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Radzikowski Poland 13 294 144 133 97 69 72 656
Teresa Barlozzari United States 14 194 0.7× 224 1.6× 556 4.2× 35 0.4× 62 0.9× 17 943
Peter Pyrko United States 8 399 1.4× 86 0.6× 70 0.5× 34 0.4× 54 0.8× 8 836
Zhi Jie Li Hong Kong 17 485 1.6× 159 1.1× 103 0.8× 42 0.4× 64 0.9× 27 824
Guillemette Chevalier France 12 431 1.5× 172 1.2× 39 0.3× 96 1.0× 79 1.1× 18 848
Klaus Fuchs Germany 15 614 2.1× 122 0.8× 143 1.1× 27 0.3× 42 0.6× 22 1.2k
Frida Ponthan United Kingdom 19 606 2.1× 197 1.4× 112 0.8× 25 0.3× 237 3.4× 33 1.1k
Rubén M. Muñoz United States 17 712 2.4× 406 2.8× 55 0.4× 34 0.4× 117 1.7× 30 1.1k
Michelle Wong United States 10 674 2.3× 181 1.3× 124 0.9× 87 0.9× 85 1.2× 18 973
Tomoko Fukushige Japan 20 520 1.8× 116 0.8× 102 0.8× 90 0.9× 85 1.2× 54 1.1k

Countries citing papers authored by C Radzikowski

Since Specialization
Citations

This map shows the geographic impact of C Radzikowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Radzikowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Radzikowski more than expected).

Fields of papers citing papers by C Radzikowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Radzikowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Radzikowski. The network helps show where C Radzikowski may publish in the future.

Co-authorship network of co-authors of C Radzikowski

This figure shows the co-authorship network connecting the top 25 collaborators of C Radzikowski. A scholar is included among the top collaborators of C Radzikowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Radzikowski. C Radzikowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Radzikowski, C. (2002). Advances in studies on invasive tumor growth and metastasis. Cellular & Molecular Biology Letters. 7. 1 indexed citations
2.
Paprocka, Maria, Agnieszka Krawczenko, Philippe Dupuis, et al.. (2002). New Human Microvascular Endothelial Cell Lines with Specific Adhesion Molecules Phenotypes. Endothelium. 9(4). 247–261. 71 indexed citations
3.
Wietrzyk, Joanna, Adam Opolski, Jan P. Madej, & C Radzikowski. (2000). Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.. PubMed. 14(2). 357–62. 10 indexed citations
4.
Opolski, Adam, Joanna Wietrzyk, Ewa Marcinkowska, et al.. (2000). Biological Activity In Vitro of Side-Chain Modified Analogues of Calcitriol. Current Pharmaceutical Design. 6(7). 755–765. 28 indexed citations
5.
Pajtasz‐Piasecka, Elżbieta, et al.. (1999). Synergistic antitumour effects of chemo-immunotherapy with an oxazaphosphorine drug and IL-2-secreting cells in a mouse colon cancer model. Medical Oncology. 16(4). 267–278. 12 indexed citations
6.
Kleinrok, Z, et al.. (1998). GABA content and GAD activity in colon tumors taken from patients with colon cancer or from xenografted human colon cancer cells growing as s.c. tumors in athymic nu/nu mice.. PubMed. 49(2). 303–10. 55 indexed citations
7.
Opolski, Adam, Joanna Wietrzyk, Danuta Duś, et al.. (1998). Metastatic potential and saccharide antigens expression of human colon cancer cells xenotransplanted into athymic nude mice. Folia Microbiologica. 43(5). 507–510. 12 indexed citations
8.
Opolski, Adam, Anna Laskowska, J.A. Madej, et al.. (1998). Metastatic potential of human CX-1 colon adenocarcinoma cells is dependent on the expression of sialosyl Le a antigen. Clinical & Experimental Metastasis. 16(8). 673–681. 18 indexed citations
9.
Pajtasz‐Piasecka, Elżbieta, et al.. (1996). Interleukin-2 gene therapy potentiates tha antitumor effect of cytostatic agent in mice with advanced transplantable tumors. Biotechnologia. 68–79. 2 indexed citations
10.
Radzikowski, C, et al.. (1996). Cytotoxicity and proliferation of splenocytes and lymph node cells from adjuvant‐treated nude mice:. Apmis. 104(7-8). 647–658. 1 indexed citations
11.
Radzikowski, C. (1995). Ocena tzw. metod alternatywnych w badaniach biomedycznych. 96(6). 150–157. 1 indexed citations
12.
Budzyński, W & C Radzikowski. (1994). Cytotoxic Cs in Immunodeficient Athymic Mice. Immunopharmacology and Immunotoxicology. 16(3). 319–346. 70 indexed citations
13.
Šímová, Jana, et al.. (1993). Utilization of interleukin-2 gene transfer in local immunotherapy of cancer. Journal of Cancer Research and Clinical Oncology. 119(5). 253–256. 3 indexed citations
14.
Radzikowski, C, et al.. (1992). Antitumor Activity Evaluation of Bromine-Substituted Analogues of Ifosfamide. I. Stereodifferentiaton of Biological Effects Amd Selection of the Most Potent Compounds. Immunopharmacology and Immunotoxicology. 14(4). 883–911. 7 indexed citations
15.
Duś, Danuta, et al.. (1992). Tumorigenicity and metastatic ability of MmB16 mouse melanoma cell line and its two Aleuria aurantia agglutinin resistant variants.. PubMed. 40(5-6). 263–9. 2 indexed citations
16.
Debray, Henri, Danuta Duś, Pablo Hueso, C Radzikowski, & Jean Montreuil. (1990). Lectin-resistant variants of mouse Lewis lung carcinoma cells. II. Altered glycosylation of membrane glycoproteins. Clinical & Experimental Metastasis. 8(3). 287–298. 5 indexed citations
17.
Duś, Danuta, et al.. (1990). Lectin-resistant variants of mouse Lewis lung carcinoma cells. I. Selection and in vivo properties. Clinical & Experimental Metastasis. 8(3). 277–286. 7 indexed citations
18.
Więdłocha, Antoni, et al.. (1989). Specific killing of mouse leukemic cells with ricin A-chain immunotoxin.. PubMed. 37(1-2). 101–13. 2 indexed citations
19.
Kuciel, R, et al.. (1988). Characterization of Anti‐Prostatic Acid Phosphatase Monoclonal Antibody and its Medical Significance. Biotechnology and Applied Biochemistry. 10(3). 257–272. 6 indexed citations
20.
Kuśnierczyk, Piotr, Adam Opolski, M. Seshadri, et al.. (1987). Genetic monitoring of inbred mouse strains maintained at the Bhabha Atomic Research Centre, Bombay: serological typing for H-2 haplotypes and lymphocyte differentiation markers.. PubMed. 35(4). 423–30. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026